Pharmacogenomics of platelet responsiveness to aspirin.

Pharmacogenomics of platelet responsiveness to aspirin.

Item
http://www.wikidata.org/entity/Q36989841
The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19Mapping genes that predict treatment outcome in admixed populationsGenome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists.The genetics of common variation affecting platelet development, function and pharmaceutical targeting.Impact of genetic variation on perioperative bleeding.Genomics: risk and outcomes in cardiac surgeryAssociations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in Chinese ischemic stroke patients receiving aspirin therapy.The pharmacogenetics of antiplatelet agents: towards personalized therapy?Pharmacogenomics of anti-platelet and anti-coagulation therapy.Common genetic variants in platelet surface receptors and its association with ischemic stroke.Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.Is preoperative withdrawal of aspirin necessary in patients undergoing elective inguinal hernia repair?Personalized healthcare in clotting disorders.
P2860

Pharmacogenomics of platelet responsiveness to aspirin.

Item
http://www.wikidata.org/entity/Q36989841
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pharmacogenomics of platelet responsiveness to aspirin.
@en
type
label
Pharmacogenomics of platelet responsiveness to aspirin.
@en
prefLabel
Pharmacogenomics of platelet responsiveness to aspirin.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Pharmacogenomics of platelet responsiveness to aspirin.
@en
P2093
P2860
P304
P31
P356
10.2217/14622416.8.10.1413
P433
P478
P577
P698
P921